Alembic Pharmaceuticals shares rise 2% after USFDA nod for key hypertension drug
Shares of Alembic Pharmaceuticals gained 2% to their day’s high of Rs 103 per share on the NSE on Monday, November 17, after the drugmaker secured a fresh approval from the U.S. Food & Drug Administration for a widely prescribed cardiovascular therapy. Alembic Pharmaceuticals informed the exchanges that it has received final approval from the…